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Abstract
One of the great strengths of the Framingham Heart Study data, provided for the Genetic Analysis
Workshop 13, is the long-term survey of phenotypic data. We used this unique data to create new
phenotypes representing the pattern of longitudinal change of the provided phenotypes, especially
systolic blood pressure and body weight. We performed a linear regression of body weight and
systolic blood pressure on age and took the slopes as new phenotypes for quantitative trait linkage
analysis using the SOLAR package. There was no evidence for heritability of systolic blood pressure
change. Heritability was estimated as 0.15 for adult life "body weight change", measured as the
regression slope, and "body weight gain" (including only individuals with a positive regression
slope), and as 0.22 for body weight "change up to 50" (regression slope of weight on age up to an
age of 50). With multipoint analysis, two regions on the long arm of chromosome 8 showed the
highest LOD scores of 1.6 at 152 cM for "body weight change" and of >1.9 around location 102 cM
for "body weight gain" and "change up to 50". The latter two LOD scores almost reach the
threshold for suggestive linkage. We conclude that the chromosome 8 region may harbor a gene
acting on long-term body weight regulation, thereby contributing to the development of the
metabolic syndrome.
Background
One of the special qualities of the Framingham Heart
Study data, provided by the Genetic Analysis Workshop
13 (GAW13), is the long-term survey of phenotypic data.
The quantitative phenotypes systolic blood pressure, body
height, body weight, fasting serum glucose, total plasma
cholesterol, high density lipoprotein cholesterol, and trig-
lycerides were measured repeatedly over a period of 40
years in the first generation of study participants and over
a period of 20 years in their offspring. We used this unique
data to create new phenotypes representing the pattern of
longitudinal change of the provided phenotypes, assum-
ing that not only the measured traits, but also their pattern
of longitudinal change, could be genetically determined.
We chose the phenotypes systolic blood pressure and
body weight because of their known tendency to increase
during adult lifespan, and because of their most complete
longitudinal survey by repeated measurements at each
examination during the study. Our own previous analyses
of the population sample of Framingham Cohort 1 and 2
from Genetic Analysis Workshop 13: Analysis of Longitudinal Family Data for Complex Diseases and Related Risk Factors
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showed that body weight and systolic blood pressure rise
linearly with age, but the gradient is steeper when the
regression is performed only up to an age of 50 compared
with the regression on all available measurements.
Another group participating in Genetic Analysis Work-
shop 13 (GAW13) analyzed the changes of body mass
index with age (BMI = weight/height2, which corresponds
to weight change, because there is almost no change of
height during adult life). They found a linear gain-phase
up to a maximum value (at about age 53 on average) and
a decline-phase later in life [1]. According to this we ana-
lyzed "body weight change" during whole life, "body
weight gain" (using phenotypes of individuals with a pos-
itive gain of weight only), and body weight "change up to
50", the regression slope of weight on age up to an age of
50.
Materials and Methods
The Framingham Heart Study data were provided as Prob-
lem 1 of GAW13. The data consisted of family structure
information, genotypic information (genome scan), and
long-term phenotypic information for 1702 subjects from
330 families. Phenotypic information was provided over
a period of 40 years for the parent generation and 20 years
for the offspring generation. Phenotypic information con-
sisted of values of repeated measurements of systolic
blood pressure, height, weight, lipids (total plasma cho-
lesterol, high density lipoprotein cholesterol, triglycer-
ides), and fasting plasma glucose. We chose the
phenotypes systolic blood pressure and body weight for
our analysis.
Statistical analysis
Linear regression was perfomed using SAS [2] for the val-
ues of systolic blood pressure and body weight, at each
time of examination, on age, for each individual sepa-
rately. To obtain the values for adult life only, individuals
younger than 18 years at the first examination were
excluded. We omitted the values of these individuals
instead of using the examinations with age 18 as a starting
point because of lower reliability of the regression slopes
(based on four time points at most and often less due to
younger age and missing values) and because of their rel-
atively low contribution due to small frequency (only 6%
of individuals of Cohort 2 and none of Cohort 1 were
younger than 18 years at their first examination). For
systolic blood pressure, measurements were omitted if
high blood pressure treatment was stated at this examina-
tion or any previous examination. The slope estimates
were obtained for all individuals and used as a new phe-
notype providing a measure of the adult life change of
systolic blood pressure and body weight. Further analyses
of body weight change were conducted with regression
slope up to an age of 50 as the phenotype "change up to
50" and with only those individuals who showed a posi-
tive weight slope (≥ 0.01), representing the phenotype
adult life "body weight gain". Heritability estimates for
the new phenotypes were obtained using variance-com-
ponent methodology as implemented in the SOLAR pack-
age [3]. Heritability estimates were done analyzing the
covariates sex, age at first examination and weight at first
examination in addition. Only age at first examination
contributed to the variance of the three phenotypes,
explaining about 12% of the variance of "body weight
change", 6% of the variance of "body weight gain", and
9% of the variance of "change up to 50". Because further
examinations were at the same regular intervals for all
individuals of the two cohorts, age at first examination
represents age-dependence during the whole study. Two-
point and multipoint quantitative trait linkage analyses
were conducted on the regression slope estimates for
adult life "body weight change", "body weight gain", and
"change up to 50", using the SOLAR package. In the case
of "body weight gain", we included age at first examina-
tion as a covariate. The information content of chromo-
somal regions with positive LOD scores was obtained
using GENEHUNTER [4].
Results
The estimated heritability for adult life "blood pressure
change" was 0.002 (not significant). For adult life "body
weight change" a heritability of 0.15 (highly significant, p
< 0.0001) was estimated. The highest two-point LOD
scores for "body weight change" for each of the 22 auto-
somal chromosomes are presented in Figure 1. The high-
est LOD scores were 1.95 at marker GATA8A05
(D4S1629) on chromosome 4, 1.8 at marker GATA6G12
(D3S2398) on chromosome 3, and 1.6 at marker
GATA7G07 (D8S1179) on chromosome 8. Information
content in these chromosomal regions varied mostly from
0.33 to 0.55 and did not exceed 0.60. All other two-point
LOD scores were below 1.5 (Figure 1, blue bars). Inclu-
sion of age at first examination in the heritability model
resulted in low two-point LOD scores (<1.6) over all chro-
mosomes and a heritability model without covariates was
used in multipoint analysis. Multipoint LOD scores
diminished with respect to the two-point LOD scores for
the regions on chromosome 3 and 4 with maximum val-
ues of 1.37 (location 207 cM on chromosome 3) and 1.10
(location 181 cM on chromosome 4). These lower values
were due to low LOD scores of the flanking markers
(between 0.06 and 0.28 for chromosome 3 and 0.06 to
0.31 for chromosome 4). Only the region on chromo-
some 8 showed stable LOD scores (maximum multipoint
LOD score 1.61 at position 152 cM) (Figure 2, blue line).
For adult life "body weight gain", which included pheno-
typic information only for those individuals with positive
slope estimates, heritability was estimated as 0.15 (highly
significant,  p  < 0.0001). Age at first examination was
included as a covariate in the heritability model with anBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S7
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estimated attributable proportion of variance of 0.06. The
highest two-point LOD score for "body weight gain" was
1.7 at GATA14E09 (D8S2324) on chromosome 8 with all
other two-point LOD scores below 1.5 (including markers
on chromosomes 3 and 4, where LOD scores for the phe-
notype "body weight change" were higher) (Figure 1, red
bars). The maximum multipoint LOD score was 1.97 at
location 103 cM (near GATA14E09) on chromosome 8
(Figure 2, red line). For "change up to 50", the regression
slope of weight on age up to an age of 50, a heritability of
0.22 (highly significant, p < 0.0001) was estimated. The
highest two-point LOD scores were on chromosome 8,
1.85 at GATA8G10 (D8S1110) and 2.06 at GATA14E09
(D8S2324), the latter marker being the position of the
highest two-point LOD score of "body weight gain", too.
All other two-point LOD scores were below 1.5 (Figure 1,
yellow bars), as were all two-point LOD scores when age
at first examination was included as a covariate in the her-
itability model. The maximum multipoint LOD score for
"change up 50" (using a heritability model without cov-
ariates) was 1.93 at 102 cM of chromosome 8 with a LOD
score peak and curve almost identical to that of "body
weight gain" (Figure 2, yellow line). The two regions of
maximum LOD scores for "body weight change" and
"body weight gain"/ "change up to 50" are about 50 cM
apart on the long arm of chromosome 8 (Figure 2).
Discussion
Adult life increase of systolic blood pressure and of body
weight are known phenomena, at least in western lifestyle
populations. Environmental factors like lack of exercise
and high food intake are major factors influencing both of
them. Yet little is known as to whether heritable factors
may contribute to the pattern of change of blood pressure
and body weight during lifetime. Our analysis using
regression slopes as a measure for lifetime changes
showed no evidence of a heritable basis of blood pressure
change, but we found heritabilities of 0.15 for "body
weight change" and "body weight gain" and of 0.22 for
body weight "change up to 50". We identified two regions
50 cM apart from one another on the long arm of chromo-
some 8 with linkage to "body weight change" (distal
Maximum two-point LOD scores for body weight change phenotypes for the 22 autosomes Figure 1
Maximum two-point LOD scores for body weight change phenotypes for the 22 autosomes. Depicted are "body 
weight change" (blue), "body weight gain" (red), and "change up to 50" (yellow).BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S7
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region) and to "body weight gain" and "change up to 50"
(proximal region). Although not significant, the LOD
scores for "body weight gain" of 1.97 and "change up to
50" of 1.93 at locations 102 and 103 cM on chromosome
8 almost reach the threshold of 2.2 for suggestive evidence
of linkage [5]. Very large sample sizes are required for
detection of a quantitative trait locus (QTL) attributable
to 10% or 15% heritability of a trait with significant LOD
scores. For instance, if 10% heritability is due to a single
QTL, 3300–33,000 individuals (depending on family
structure) are required to obtain a LOD score of 3.0 with
80% power [6]. The Framingham Heart Study sample
with 1702 subjects from 330 families is very big, yet it may
well be not big enough to obtain statistically significant
linkage results for traits with total heritabilities of 0.15 to
0.22, even if a single locus would attribute to 0.67 or 0.50
of the heritability. We therefore think, that "almost sug-
gestive linkage" is probably the best obtainable result for
the body change traits we analyzed, and that confirmation
would require analysis (or meta-analysis) of still larger
sample sizes.
Interestingly, two other groups participating in the
Derived Phenotypes Group of GAW13 reported related
results with different (but pathophysiologically related)
phenotypes. Jun et al. found statistically significant evi-
dence of linkage between the region on chromosome 8
around marker GATA21C12 and fasting glucose levels
progression (exactly the same region which we identified
for "body weight change") [7]. Wilcox et al. derived four
phenotypically distinct groups using correspondence
analysis and clustering. One of these groups resembled
atherogenic dyslipidemia and the metabolic syndrome.
Besides other chromosomal regions, they found the same
chromosome 8 location (two-point LOD scores above
two for markers GATA7G07, UT721, GATA21C12) for
their metabolic-syndrome-like phenotype as we found for
"body weight change" [8]. The region on chromosome 3,
where we obtained a relatively high two-point LOD score
for "body weight change", contains AOMS1 (abdominal
obesity-metabolic syndrome QTL1), the first known met-
abolic syndrome QTL [9]. These findings underscore the
pathophysiological relationship between body weight
Multipoint LOD scores for body weight change phenotypes on chromosome 8 Figure 2
Multipoint LOD scores for body weight change phenotypes on chromosome 8. Depicted are "body weight change" 
(blue), "body weight gain" (including the covariate age at first examination) (red), and "change up to 50" (yellow).Publish with BioMed Central    and   every 
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change (body weight gain), blood glucose level
progression, and the metabolic syndrome, and point to a
long-term body weight regulating gene on chromosome 8
that may play a role in the development of the metabolic
syndrome.
Conclusion
Longitudinal data like that collected in the Framingham
Heart Study provided for GAW13 enable the search not
only for genes influencing the phenotypes themselves, but
also for genes contributing to the pattern of change during
lifetime. Using regression slope estimates as a parameter
for longitudinal change of body weight, we found evi-
dence for a long-term body weight regulating gene located
on the long arm of chromosome 8. Combining our results
with the findings of other GAW13 participants [7,8], we
think that this gene might be involved in the development
of the metabolic syndrome by influencing long-term body
weight and consequently blood glucose level. Location of
genes involved in long-term regulation of physiological
processes can be found using phenotypes derived from
longitudinal data, and exactly those long-term regulatory
genes may play key roles in frequent diseases of late onset.
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